Refine by
Pseudomonas Articles & Analysis
58 news found
The CRISPR/Cas system is widely used in basic research and biotechnology applications, including genome editing, molecular diagnosis, metabolic engineering, and gene function mining in microorganisms, plants, and mammals.In the field of microbial biotechnology, the CRISPR/Cas system has been applied to many model and non-model microorganisms, including Escherichia coli, Saccharomyces cerevisiae, ...
One of the more commonly isolated types of bacteria from MWFs is Pseudomonas. Others include Klebsiella pneumoniae, Staphylococcus aureus, Enterobacter, and more. ...
The study was performed using two representative species of bacteria – Gram-positive methicillin-resistant Staphylococcus aureus (MRSA) and Gram-negative Pseudomonas aeruginosa. The irrigation solutions evaluated in the study involved an array of antimicrobial technologies and preservatives, including acids, surfactants, chlorhexidine gluconate (CHG), benzalkonium chloride ...
The integration of the C-His tag in the recombinant Pseudomonas sp. Formaldehyde Dehydrogenase not only enhances its stability and solubility but also simplifies the purification process, making it an ideal choice for industrial applications. ...
The number of patients treated for an extensively drug-resistant strain of Pseudomonas aeruginosa, over 100 patients were blinded in at least one eye and 4 deaths, cases were discovered in over 18 states across America. ...
Of the many different types of Pseudomonas, the one that most often causes infections in humans is known as Pseudomonas aeruginosa according to the Centers for Disease Control and Prevention (CDC). The bacteria can cause infections in the blood, lungs, and potentially other parts of the body. While Pseudomonas aeruginosa lives in the natural ...
An inoculum equivalent to 0.5 McFarland turbidity standard is then prepared from each isolated Pseudomonas aeruginosa and placed in Müller-Hinton broth. Finally, 100 μl of 5 x 105 CFU/ml bacterial inoculum is inoculated into each microwell and incubated for 48 hours at 35°C under aerobic conditions. ...
Pseudomonas is a type of bacteria that is found commonly in the environment, often in places like soil and water. Of the many different types of Pseudomonas, the one that most often causes infections in humans is known as Pseudomonas aeruginosa according to the Centers for Disease Control and Prevention (CDC). ...
Their newest production discusses a bacterium known as Pseudomonas aeruginosa that can cause infections in the blood, lungs and potentially other parts of the body. “While Pseudomonas aeruginosa lives in the natural environment, it can also sometimes be found in the built environment where it can be spread to people, especially those in healthcare ...
The two genetic modifications to control maize for corn rootworm pests consist of the expression of DvSSJ1 double-stranded RNA (dsRNA), targeting the smooth septate junction protein 1 gene (DvSSJ1) of the western corn rootworm (Diabrotica virgifera virgifera) and the expression of the insecticidal IPD072Aa protein derived from Pseudomonas chlororaphis. For herbicide tolerance, ...
Microbion Corporation today announced that the company presented a poster highlighting the effect of pravibismane on bacterial energetics in Pseudomonas aeruginosa, Staphylococcus aureus, Escherichia coli and Mycobacterium avium species at ASM Microbe 2022 in Washington, DC. ...
(NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that the Company will host a virtual key opinion leader (“KOL”) webinar on BX004 for the treatment of Pseudomonas Aeruginosa (“PsA”) ...
ByBiomX
The names of the killers are the Gram-negative bacteria Acinetobacter baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Escherichia coli, and the Gram-positive bacteria Staphylococcus aureus and Streptococcus pneumoniae. ...
BiomX is developing BX004 for the treatment of chronic respiratory infections in CF patients caused by Pseudomonas aeruginosa, a main contributor to morbidity and mortality in patients with CF. ...
ByBiomX
The KapaVax candidate targets include three of the most worrisome antibiotic-resistant bacteria of the list of the WHO: Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii, for which there are not available vaccines yet. ...
Tolerance to isoxaflutole herbicides is achieved by the expression of a modified p hydroxyphenyl pyruvate-dioxygenase (HPPD) protein, encoded by the hppdPf W336 gene, derived from the soil bacterium Pseudomonas fluorescens [1]. EU Regulation No 1829/2003 [2] requests that reference materials are made available for GMO events authorised for the EU food and feed market. ...
For herbicide tolerance, it has a Pseudomonas fluorescens HPPD gene with point mutations in the C-terminal to allow for and enhance tolerance to HPPD-inhibitor herbicides, such as isoxaflutole and mesotrione [1].EU Regulation No 1829/2003 [2] requests that reference materials are made available for GMO events authorised for the EU food and feed market. ...
K192665, features improvements in susceptibility testing performance for four important antibiotics used to treat Pseudomonas aeruginosa, as well as the addition of the combination of P. aeruginosa and aztreonam, an empiric antibiotic, to the Accelerate PhenoTest BC kit testing panel. ...
KapaVax, the Vaxdyn project funded by CARB-X, is under development as a prophylactic vaccine for the prevention of infections caused by drug-resistant Gram-negative pathogens including Acinetobacter baumannii, Klebsiella pneumoniae and Pseudomonas aeruginosa in multiple at-risk populations. These three bacterial pathogens are deemed serious public health threats. ...
The solution produced kills 99.9% of every pathogen; including E. Coli (Escherichia coli), Pseudomonas, Enterococcus, C. Diff spores, and staphylococcus. Unlike many other sanitation chemicals, hypochlorous acid does not have an ongoing antimicrobial effect. ...
